About: Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 March 2000

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) wüsseschaftlicher Artikel, wo im März 2000 veröffentlicht worden isch (gsw) im März 2000 veröffentlichter wissenschaftlicher Artikel (de) наукова стаття, опублікована в березні 2000 (uk) artículu científicu espublizáu en marzu de 2000 (ast) scientific article published on 01 March 2000 (en)
publication date	wds:Q73548256-35AE778F-ADC7-4C6E-B0B8-2A70280C8029
publication date	2000-03-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q73548256-F9FDC17D-FD93-4B11-BE34-E371419B6DBB
language of work or name	English
author name string	wds:Q73548256-030B888E-BD30-4E64-A226-F8CF936AEA81 wds:Q73548256-2AF1855B-9F84-45C1-9666-4368DA87057B wds:Q73548256-4663E71D-DD91-429F-A7FB-F9E1972EA4A0 wds:Q73548256-4AE938C8-7DBC-4E89-9538-A7E3698B3C04 wds:Q73548256-7238B1FC-0DF3-423B-B11F-328342123A3E wds:Q73548256-A4649A42-F68B-45EA-86DD-DBA634F631C5 wds:Q73548256-AB59A15F-947C-43ED-A5F1-370BE4EABC1F wds:Q73548256-AF0F7090-B5E3-44D2-922F-C30F38D14766 wds:Q73548256-C1DB0B9A-BA82-4DAD-8BED-98B37AE12081 wds:Q73548256-C3F18770-AF8C-458C-9AEC-586B0CCCD299 wds:Q73548256-C8694252-1D11-4BAA-9B1C-C7FF4E3C39BB wds:Q73548256-DB3CC344-2C96-40D9-934D-DE14BD5B5F38
author name string	Silverman ED Stein LD Wallace CA Ilowite NT Lovell DJ Nocton JJ Giannini EH Whitmore J Finck BK Gedalia A Reiff A Cawkwell GD
rdfs:label	Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group (en) Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group (nl)
skos:prefLabel	Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group (en) Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group (nl)
name	Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group (en) Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group (nl)
title	wds:Q73548256-D234261B-BE9F-4389-BE50-B992AE32B843
title	Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group (en)
page(s)	wds:Q73548256-F15C6D69-827C-4C28-A956-E27C202CAFFF
page(s)	763-769
instance of	wds:Q73548256-FEF442A7-7E1B-4CE4-A8C5-38600BB44BA6
instance of	scholarly article
main subject	wds:Q73548256-63026D51-650B-4A4C-B32A-9617D54E566A
main subject	juvenile rheumatoid arthritis
PubMed ID	wds:Q73548256-9A888B17-2E30-41FD-AEBE-06BB6F3B5A22
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10717011
PubMed ID	10717011
published in	wds:Q73548256-E8C3EF36-4D08-4399-8835-31D9DFC34314
published in	The New England Journal of Medicine
issue	wds:Q73548256-0A99FC3D-3AFC-4AC9-B441-6CD4756AFA47
volume	wds:Q73548256-D4902F14-4B7E-43AC-99C1-B0E9FC8A863A
issue	11
volume	342
DOI	wds:Q73548256-45523F6F-0372-4629-8513-3499DB103DF2
DOI	http://dx.doi.org/10.1056/NEJM200003163421103
DOI	10.1056/NEJM200003163421103
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73548256
is cites work of	Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial Psoriasis: emerging therapeutic strategies Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade Development of anti-TNF therapy for rheumatoid arthritis Autoimmune aspects of cytokine and anticytokine therapies Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension. Recent developments in anti-rheumatic drugs in pediatrics: treatment of juvenile idiopathic arthritis Consensus procedures and their role in pediatric rheumatology. Tumor necrosis factor inhibitors: clinical utility in autoimmune diseases Network in pediatric rheumatology: the example of the Pediatric Rheumatology International Trials Organization Infections and anti–tumor necrosis factor α therapy Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other immune mediated inflammatory diseases (May 2003). Etanercept (Enbrel): update on therapeutic use Biologic therapies for juvenile arthritis Preliminary findings regarding proinflammatory markers and brain-derived neurotrophic factor among adolescents with bipolar spectrum disorders Infection complications associated with the use of biologic agents Cytokines in rheumatoid arthritis: trials and tribulations Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial The German etanercept registry for treatment of juvenile idiopathic arthritis 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features Inhibition of IL-1, IL-6, and TNF-alpha in immune-mediated inflammatory diseases Juvenile idiopathic arthritis Experimental designs for small randomised clinical trials: an algorithm for choice Successful treatment of refractory adult-onset Still's disease with infliximab. A prospective, non-comparative series of four patients. Biologic treatment response among adults with juvenile idiopathic arthritis: results from the British Society for Rheumatology Biologics Register Follistatin-like protein 1 is a mesenchyme-derived inflammatory protein and may represent a biomarker for systemic-onset juvenile rheumatoid arthritis Effector lymphocytes in autoimmunity Novel, non-antigen-specific therapeutic approaches to autoimmune/inflammatory diseases Autologous hemopoietic stem-cell transplantation for children with refractory autoimmune disease Spironolactone inhibits production of proinflammatory cytokines, including tumour necrosis factor-alpha and interferon-gamma, and has potential in the treatment of arthritis Juvenile Idiopathic Arthritis: Diagnosis and Treatment Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study Randomized, double-blind, placebo-controlled trial of the efficacy and safety of rilonacept in the treatment of systemic juvenile idiopathic arthritis Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial Rates of malignancy associated with juvenile idiopathic arthritis and its treatment Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study. Guilt by association - what is the true risk of malignancy in children treated with etanercept for JIA?

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software